Is tranexamic acid going to CRASH the management of traumatic brain injury?

Intensive Care Med. 2020 Jun;46(6):1261-1263. doi: 10.1007/s00134-019-05879-5. Epub 2019 Dec 9.

Authors

Fabio Silvio Taccone¹, Giuseppe Citerio², Nino Stocchetti³

Affiliations

¹ Department of Intensive Care, Hôpital Erasme, Route de Lennik, 808, 1070, Brussels, Belgium. ftaccone@ulb.ac.be.
² Neurointensive Care Unit, San Gerardo Hospital, ASST-Monza, Monza, MB, Italy.
³ Department of Physiopathology and Transplant, Milan University-Neuro ICU, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.

PMID: 31820035
DOI: 10.1007/s00134-019-05879-5

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antifibrinolytic Agents* / therapeutic use
Brain Injuries* / drug therapy
Brain Injuries, Traumatic* / drug therapy
Humans
Tranexamic Acid* / therapeutic use
Vascular Diseases*

Substances

Antifibrinolytic Agents
Tranexamic Acid